Results 271 to 280 of about 1,052,864 (307)
Some of the next articles are maybe not open access.
Evaluation of the Peripheral Dose to Uterus in Breast Carcinoma Radiotherapy
Radiation Protection Dosimetry, 2002The absorbed dose outside of the direct fields of radiotherapy treatment (or peripheral dose, PD) is responsible for radiation exposure of the fetus in pregnant women. Because the radiological protection of the unborn child is of particular concern in the early period of the pregnancy, the aim of this study is to estimate the PD in order to assess the ...
C, Martín Rincón +7 more
openaire +2 more sources
Defining a Therapeutic Dose of Peripheral Blood Stem Cells
Journal of Hematotherapy, 1992Peripheral blood stem cells (PBSC) are now used extensively to provide rapid and durable hematopoietic reconstitution following supralethal myeloablative therapies. A major clinical issue is the quantitation of the cells responsible for reconstitution.
J G, Bender +3 more
openaire +2 more sources
High dose etoposide does not cause peripheral neuropathy
Cancer Chemotherapy and Pharmacology, 1987L'etoposide n'est pas un agent neurotoxique et peut etre utilise meme en presence de lesions nerveuses ...
T J, Littlewood +2 more
openaire +2 more sources
High-dose chemotherapy with peripheral blood progenitor autografting
1995Mobilized PBPs are an acceptable alternative to ABMT for hematopoietic rescue following high-dose therapy (table 10-3). Platelet recovery appears to be faster following PBPs than ABMT. In most series, leukocyte recovery is also accelerated, but this may be particularly due to the use of colony-stimulating factor.
J P, Crown, D, Fennelly
openaire +2 more sources
Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?
Clinical Breast Cancer, 2007The rationale for intensification strategies is that more frequent exposure to chemotherapeutics could enhance antitumor activity. Several trials investigated weekly paclitaxel administration, but there are no clear data concerning peripheral neurotoxicity.
Pace A +11 more
openaire +3 more sources
Painful peripheral neuropathy after treatment with high‐dose ifosfamide
Medical and Pediatric Oncology, 2001AbstractBackgroundIfosfamide is successfully employed in the treatment of bone and soft tissue sarcomas in children and young adults. Used at high doses (HDI) the drug may cause severe multiorgan toxicity. Peripheral neuropathy is a less well‐known side effect that may limit its use.
P, Frisk +3 more
openaire +2 more sources
The Role of High-Dose Therapy in Peripheral T-Cell Lymphomas
Clinical Lymphoma and Myeloma, 2006Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of non-Hodgkin's lymphomas. With few exceptions (eg, anaplastic large-cell lymphoma expressing the anaplastic lymphoma kinase), PTCLs have generally been reported to have a worse prognosis compared with B-cell lymphomas.
Peter, Reimer +2 more
openaire +2 more sources
Dose-Dependent Effects of Meclofenamate on Peripheral Vasculature of Conscious Rabbits
Clinical Science, 19831. Changes in systemic haemodynamics and organ blood flow were measured in conscious rabbits after various doses of intravenous sodium meclofenamate, an inhibitor of prostaglandin cyclo-oxygenase. 2. Meclofenamate had no effect on arterial pressure or cardiac output but caused a dose-dependent fall in renal blood flow.
R A, Banks, L J, Beilin, J, Soltys
openaire +2 more sources
Local Low-Dose Thrombolytic Therapy of Peripheral Arterial Occlusions
New England Journal of Medicine, 1982Local thrombolytic therapy has previously been used in selected patients to treat obstructive arterial lesions.1 2 3 The methods of these earlier investigators involved insertion of a catheter into...
H, Hess +3 more
openaire +2 more sources
Typical Dose of Intravenous Norepinephrine Administered Peripherally
Anesthesia & Analgesia, 2021openaire +2 more sources